↓ Skip to main content

Dove Medical Press

Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, January 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
47 Mendeley